Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 6, 2023JAMA NeurologyOpen Access

Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAhmed AbdelhakPBPascal BenkertSSSabine Schaedelin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abdelhak et al. (2023) studied this question.

synapsesocial.com/papers/6a9cc0346a0b47dac776f0a8https://doi.org/10.1001/jamaneurol.2023.3997
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis2022 · 188 citations
  2. 2Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years2019 · 204 citations
  3. 3Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study2017 · 159 citations
  4. 4Blood Neurofilament Light in Progressive Multiple Sclerosis2022 · 50 citations
  5. 5Blood neurofilament light chain as a biomarker of MS disease activity and treatment response2019 · 584 citations